|
NUP205 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.029600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.270800E-01 |
| Normal-vs-Stage2 |
1.575850E-01 |
| Normal-vs-Stage3 |
4.082400E-02 |
| Normal-vs-Stage4 |
2.091800E-02 |
| Stage1-vs-Stage2 |
4.732800E-01 |
| Stage1-vs-Stage3 |
2.300600E-01 |
| Stage1-vs-Stage4 |
1.201190E-01 |
| Stage2-vs-Stage3 |
8.829600E-01 |
| Stage2-vs-Stage4 |
6.663400E-01 |
| Stage3-vs-Stage4 |
7.104200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.495600E-02 |
| Normal-vs-AfricanAmerican |
8.425800E-01 |
| Normal-vs-Asian |
7.551600E-01 |
| Caucasian-vs-AfricanAmerican |
1.982810E-01 |
| Caucasian-vs-Asian |
1.418960E-01 |
| AfricanAmerican-vs-Asian |
9.530800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.962300E-03 |
| Normal-vs-Female |
1.895610E-01 |
| Male-vs-Female |
3.068100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.193800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.156300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.970100E-02 |
| Normal-vs-Age(81-100Yrs) |
7.462400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.521200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.946550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.512000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.219000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.289400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.129400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.381900E-02 |
| Classical-VS-Follicular |
1.231910E-04 |
| Classical-VS-Other |
1.259010E-01 |
| Classical-VS-Normal |
8.287000E-01 |
| Tall-VS-Follicular |
9.455600E-01 |
| Tall-VS-Other |
7.775400E-01 |
| Tall-VS-Normal |
8.178300E-03 |
| Follicular-VS-Other |
8.316200E-01 |
| Follicular-VS-Normal |
1.601620E-03 |
| Other-VS-Normal |
6.134100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.598400E-02 |
| Normal-vs-N1 |
6.799700E-02 |
| N0-vs-N1 |
7.377200E-01 |
|
|
